GO:0003999 adenine phosphoribosyltransferase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0003999 describes adenine phosphoribosyltransferase (APRT) activity, the enzyme that catalyzes AMP + diphosphate = adenine + 5-phospho-alpha-D-ribose 1-diphosphate, recycling adenine into the purine nucleotide pool.
APRT deficiency in humans causes 2,8-dihydroxyadenine urolithiasis and crystalline nephropathy, an underdiagnosed inherited purine disorder.
APRT is conserved from plants and yeast to protozoan parasites and mammals, making it a tractable model enzyme for purine salvage studies.
The enzyme is a phosphoribosyltransferase that uses 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) as the ribose-phosphate donor and releases diphosphate.
APRT activity is regulated by substrate availability, developmental and metabolic cues, and has been linked to iron-deficiency responses in plants.
CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of APRT function in disease and metabolism.

Description

Adenine phosphoribosyltransferase activity (GO:0003999) is a molecular function defined as the catalysis of the reaction AMP + diphosphate = adenine + 5-phospho-alpha-D-ribose 1-diphosphate. This reaction is a central step of purine salvage, allowing free adenine to be converted into AMP and thereby re-entering the nucleotide pool rather than being degraded. Because purine homeostasis is essential for DNA and RNA synthesis, energy metabolism and signaling, the enzyme carrying this activity has been studied across organisms, from plants and yeast to protozoan parasites and humans. In humans, inherited loss of APRT activity causes adenine phosphoribosyltransferase deficiency, a disorder characterized by 2,8-dihydroxyadenine crystal formation and kidney disease. In children, the condition can present with recurrent urolithiasis and renal impairment, underscoring the clinical importance of this single enzymatic step. In plants, APRT activity is induced under iron deficiency and has been proposed to contribute to phytosiderophore production, linking purine salvage to micronutrient acquisition. In the protozoan parasite Trypanosoma brucei brucei, two APRT isoforms exist but only one is kinetically active, illustrating how this activity can be diversified and regulated at the isoform level. Together, these observations make GO:0003999 a compact but powerful entry point for studying purine metabolism, inherited disease and metabolic adaptation.

adenine phosphoribosyltransferase activity At A Glance

GO ID GO:0003999
GO term adenine phosphoribosyltransferase activity
Ontology molecular_function
Synonym APRT activity; adenine phosphoribosylpyrophosphate transferase activity; AMP pyrophosphorylase activity; AMP:diphosphate phospho-D-ribosyltransferase activity
Definition Catalysis of the reaction: AMP + diphosphate = adenine + 5-phospho-alpha-D-ribose 1-diphosphate
Major function Purine salvage: conversion of adenine to AMP using PRPP as the phosphoribosyl donor
Substrates Adenine and 5-phospho-alpha-D-ribose 1-diphosphate (PRPP)
Products AMP and diphosphate
Related disease Adenine phosphoribosyltransferase deficiency with 2,8-dihydroxyadenine urolithiasis and nephropathy
Model organisms Human, Saccharomyces cerevisiae, Trypanosoma brucei brucei, Hordeum vulgare and other plants

What Is GO:0003999?

In plain terms, GO:0003999 describes the enzymatic activity that attaches adenine to a ribose-phosphate donor to make AMP. Formally, it is the catalysis of the reaction AMP + diphosphate = adenine + 5-phospho-alpha-D-ribose 1-diphosphate. The enzyme uses 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) as the phosphoribosyl donor and releases diphosphate, effectively salvaging adenine into the purine nucleotide pool. This activity is also known by synonyms such as APRT activity, adenine phosphoribosylpyrophosphate transferase activity, AMP pyrophosphorylase activity and AMP:diphosphate phospho-D-ribosyltransferase activity.

Why Is adenine phosphoribosyltransferase activity Important in Cell Biology?

GO:0003999 matters because it defines the only known route by which free adenine is efficiently recycled into AMP in many organisms, and its failure has direct clinical consequences. In humans, biallelic APRT mutations cause adenine phosphoribosyltransferase deficiency, in which adenine is oxidized to 2,8-dihydroxyadenine, a highly insoluble compound that forms crystals and stones in the urinary tract and can lead to chronic kidney disease. Because the enzyme is conserved, studies in yeast, plants and protozoa provide mechanistic and evolutionary insight that informs human genetics. The activity is also a useful experimental handle: it can be measured biochemically, perturbed genetically and modeled in cell systems, making it an attractive target for functional genomics and drug discovery.
Provides the main salvage route for adenine into AMP, supporting nucleotide pool homeostasis.
Loss of function causes 2,8-dihydroxyadenine urolithiasis and crystalline nephropathy in humans.
Presents in children with recurrent stones and renal impairment, requiring early diagnosis.
Is conserved in yeast, plants and protozoa, enabling comparative mechanistic studies.
In plants, APRT activity is induced by iron deficiency and may support phytosiderophore production.
In Trypanosoma brucei brucei, isoform-specific kinetics illustrate regulatory diversification.
Serves as a selectable marker and metabolic reporter in yeast genetics.
Links purine salvage to developmental and hormonal signals in plant tissues.
Offers a defined biochemical readout for CRISPR-based functional validation.
Informs diagnosis and monitoring of an underrecognized inherited kidney disease.

What Happens During adenine phosphoribosyltransferase activity?

Substrate binding and formation of the enzyme-substrate complex
In simple terms: The enzyme first grabs adenine and a ribose-phosphate donor called PRPP.
APRT activity begins with binding of adenine and 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) in the active site, positioning the substrates for catalysis. The reaction is a phosphoribosyl transfer, in which the ribose-phosphate moiety of PRPP is transferred to adenine. In Trypanosoma brucei brucei, two APRT isoforms have been described, but only one displays kinetically active catalysis, indicating that substrate binding and turnover can be isoform-dependent.
Catalysis and formation of AMP
In simple terms: The enzyme glues the ribose-phosphate onto adenine to make AMP.
The catalytic step converts adenine plus PRPP into AMP plus diphosphate, as defined for GO:0003999. This reaction salvages adenine, preventing its accumulation and allowing it to re-enter the purine nucleotide pool. In humans, efficient AMP formation is critical because when APRT activity is absent, adenine is instead oxidized to 2,8-dihydroxyadenine, which is poorly soluble and crystallizes in the kidney.
Product release and metabolic fate of AMP
In simple terms: After AMP is made, it is released and used by the cell.
Following catalysis, AMP and diphosphate are released, and AMP can be phosphorylated to ADP and ATP or used in nucleic acid synthesis. The balance between salvage and de novo synthesis depends on APRT activity and PRPP availability. In plants, increased APRT activity under iron deficiency has been proposed to support production of phytosiderophores, linking AMP salvage to micronutrient acquisition.
Physiological context of the reaction
In simple terms: Where and when the enzyme works depends on the organism and tissue.
In humans, APRT is expressed in many tissues and is particularly relevant in the kidney, where loss of activity leads to crystal deposition. In Saccharomyces cerevisiae, APRT mutants have been isolated and used to study purine salvage genetics. In plant tissues, APRT activity is influenced by kinetin, indicating hormonal control of the reaction. In Trypanosoma brucei brucei, the parasite relies on purine salvage, and APRT isoform activity contributes to this dependency.

Key Genes Involved in GO:0003999 adenine phosphoribosyltransferase activity

The following genes and proteins are directly or experimentally linked to adenine phosphoribosyltransferase activity (GO:0003999) and its study across organisms.
GeneMajor RoleResearch Relevance
APRT (human)Encodes adenine phosphoribosyltransferase, the enzyme with GO:0003999 activityMutations cause APRT deficiency and 2,8-dihydroxyadenine urolithiasis
APRT (Saccharomyces cerevisiae)Yeast ortholog used in purine salvage geneticsAPRT mutants enable pathway dissection
APRT (Trypanosoma brucei brucei)Parasite enzyme with two isoforms, one kinetically activeModel for isoform-specific enzyme regulation
APRT (Hordeum vulgare)Barley enzyme induced by iron deficiencyLinks purine salvage to phytosiderophore production
APRT (plant tissues)Enzyme activity modulated by kinetinHormonal regulation of purine salvage
PRPP synthetaseProduces PRPP, the phosphoribosyl donor for APRTDetermines substrate supply for GO:0003999
Adenine deaminaseCompetes with APRT for adenineShunts adenine toward 2,8-dihydroxyadenine when APRT is deficient
Xanthine oxidaseOxidizes adenine-derived purinesContributes to 2,8-dihydroxyadenine formation
HPRT1Parallel purine salvage enzyme for hypoxanthine/guanineComparative studies of purine salvage
AMP deaminaseDegrades AMPBalances AMP pools generated by APRT
Adenosine kinasePhosphorylates adenosineAlternative salvage route intersecting with APRT
NAMPTNAD+ biosynthesis enzymeMetabolic context of purine and NAD+ pathways
AMPKEnergy sensorLinked to NAD+ and SIRT signaling in aging models
SIRT1NAD+-dependent deacetylaseDownstream of NAMPT/NAD+ axis
miR-146aMicroRNA targeting NAMPTRegulates NAD+ and AMPK signaling

How Is adenine phosphoribosyltransferase activity Regulated?

APRT activity is regulated at multiple levels. Substrate availability, especially PRPP supply, sets the flux through the reaction. In plants, APRT activity is induced under iron deficiency, indicating nutritional regulation, and is also modulated by kinetin, pointing to hormonal control. In Trypanosoma brucei brucei, two APRT isoforms exist but only one is kinetically active, showing that isoform expression and intrinsic kinetics regulate the activity. In humans, loss-of-function mutations in APRT define the disease state, and residual activity determines clinical severity. Broader metabolic context includes NAD+ and AMPK signaling, which influence purine and energy metabolism.

adenine phosphoribosyltransferase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
APRTAdenine phosphoribosyltransferase deficiency with 2,8-dihydroxyadenine urolithiasisAPRT knockout human cell lines and mouse models
APRTPediatric urolithiasis and renal impairmentPatient-derived cells and organoids
APRT (yeast)Purine salvage geneticsSaccharomyces cerevisiae APRT mutants
APRT (Trypanosoma brucei brucei)Parasite purine salvageIsoform-specific knockout and kinetic assays
APRT (barley)Iron-deficiency response and phytosiderophore productionPlant iron-deficiency models
Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadenine urolithiasis
Biallelic mutations in APRT cause adenine phosphoribosyltransferase deficiency, an inherited purine disorder in which adenine accumulates and is oxidized to 2,8-dihydroxyadenine. Because 2,8-dihydroxyadenine is highly insoluble, it forms crystals and stones in the urinary tract, leading to urolithiasis and crystalline nephropathy. The condition is underdiagnosed and can progress to chronic kidney disease if not recognized.
Pediatric presentation and renal outcomes
In children, APRT deficiency can present with recurrent kidney stones and impaired renal function, and early diagnosis is important to prevent irreversible damage. Clinical awareness and biochemical confirmation of APRT activity are key to distinguishing this disorder from other causes of urolithiasis.
Comparative and metabolic disease relevance
Studies in yeast, plants and protozoa show that APRT activity is embedded in broader metabolic networks, including iron-deficiency responses in barley and purine salvage in Trypanosoma brucei brucei. These models help explain how perturbations in purine salvage can have organism-specific consequences.

From adenine phosphoribosyltransferase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of APRT cause adenine accumulation and crystal formation?APRT knockout cell lines and animal models
Which APRT isoform carries catalytic activity?Isoform-specific knockout or point mutation in Trypanosoma brucei brucei
Can residual APRT activity predict disease severity?Patient-derived cells with defined APRT mutations
How does APRT activity respond to iron deficiency?Plant iron-deficiency experiments with APRT reporters
Is APRT required for purine salvage in yeast?Yeast APRT mutants and growth assays
Can APRT be used as a selectable marker?Yeast and mammalian cell selection systems

How to Study the adenine phosphoribosyltransferase activity Process

MethodWhat It MeasuresTypical Application
Enzyme activity assayConversion of adenine and PRPP to AMPDiagnosis and kinetic characterization
CRISPR knockoutLoss of APRT functionCausal testing in cell models
Point mutation knock-inEffect of specific APRT variantsGenotype-phenotype correlation
Metabolite profilingAdenine and 2,8-dihydroxyadenine levelsDisease monitoring
Crystal detectionPresence of 2,8-dihydroxyadenine crystalsRenal pathology assessment
Yeast geneticsPurine salvage pathway functionModel organism studies
Parasite isoform assaysIsoform-specific APRT kineticsTrypanosoma brucei brucei research
Plant iron-deficiency assaysAPRT induction and phytosiderophore productionPlant nutrition studies
Biochemical enzyme assays
APRT activity can be measured directly by monitoring the conversion of adenine and PRPP to AMP and diphosphate, as defined for GO:0003999. Such assays are used to confirm loss of function in patient samples and to compare isoform kinetics in parasites.
Genetic and CRISPR-based perturbation
Knockout, point-mutation and knock-in models allow causal testing of APRT variants. In yeast, APRT mutants have been used to dissect purine salvage pathways. In Trypanosoma brucei brucei, isoform-specific perturbations reveal which enzyme copy is active.
Metabolite profiling and crystal detection
Because APRT deficiency leads to 2,8-dihydroxyadenine accumulation, metabolite profiling and crystal detection are central readouts. These methods connect enzyme activity to clinical phenotype.
Expression and reporter studies in plants
In plants, APRT activity has been monitored under iron deficiency and in response to kinetin, using enzyme activity assays and reporter systems. These approaches link GO:0003999 to nutritional and hormonal responses.

How CRISPR Can Be Used to Study GO:0003999 adenine phosphoribosyltransferase activity

Knockout

CRISPR knockout of APRT eliminates adenine phosphoribosyltransferase activity, modeling the human deficiency state and allowing measurement of adenine accumulation and 2,8-dihydroxyadenine formation. Knockout models are also useful in yeast and parasite systems to test pathway dependencies.

Point Mutation

Point-mutation knock-in can recreate patient-specific APRT variants to determine residual activity and genotype-phenotype relationships. Such models help distinguish complete from partial loss of function.

Knock-in

Tagged or reporter knock-in of APRT enables tracking of enzyme localization and expression in cells and tissues. Knock-in of orthologs can be used to test functional conservation across species.

Overexpression

Overexpression of APRT increases flux through the salvage pathway and can be used to test whether enhanced adenine recycling alters nucleotide pools or disease phenotypes. In plants, overexpression studies can probe the link between APRT activity and iron-deficiency responses.

How EDITGENE Supports adenine phosphoribosyltransferase activity Research

Researchers studying adenine phosphoribosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in purine salvage, crystal formation or metabolic adaptation. EDITGENE provides the CRISPR and bioinformatics toolkit to move from correlation to causation across cell and model systems.
Contact EDITGENE today to design your custom CRISPR model for adenine phosphoribosyltransferase activity research.

Frequently Asked Questions About adenine phosphoribosyltransferase activity

It is the enzymatic activity defined by GO:0003999, catalyzing AMP + diphosphate = adenine + 5-phospho-alpha-D-ribose 1-diphosphate, which salvages adenine into AMP.
The main gene is APRT, with orthologs studied in yeast, Trypanosoma brucei brucei and plants.
APRT deficiency causes 2,8-dihydroxyadenine urolithiasis and crystalline nephropathy, and can present in children with kidney stones.
It is measured by enzyme assays that follow the conversion of adenine and PRPP to AMP, often combined with metabolite profiling.
Yes, APRT activity has been studied in humans, yeast, protozoan parasites and plants, showing functional conservation.
The reaction is AMP + diphosphate = adenine + 5-phospho-alpha-D-ribose 1-diphosphate.
It recycles adenine into AMP, preventing adenine accumulation and supporting nucleotide pools.
Yes, knockout, point-mutation, knock-in and overexpression models allow causal testing of APRT function.
Synonyms include APRT activity, adenine phosphoribosylpyrophosphate transferase activity and AMP pyrophosphorylase activity.
APRT activity is induced in iron-deficient barley roots and has been linked to phytosiderophore production.

Conclusion

GO:0003999 adenine phosphoribosyltransferase activity defines a compact but clinically and metabolically important reaction that salvages adenine into AMP. Its loss causes a well-characterized inherited kidney disease, while its conservation across species makes it a versatile model for purine metabolism. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with biochemical and bioinformatic readouts, provide a direct route to causal understanding of this activity in health and disease.

References

  1. 1. Adam MP et al.. 1993. Adenine Phosphoribosyltransferase Deficiency.. PMID: 22934314
  2. 2. Bollée G et al.. 2012. Adenine phosphoribosyltransferase deficiency.. Clin J Am Soc Nephrol 7(9):1521-7 PMID: 22700886
  3. 3. Gong H et al.. 2022. miR-146a impedes the anti-aging effect of AMPK via NAMPT suppression and NAD(+)/SIRT inactivation.. Signal Transduct Target Ther 7(1):66 PMID: 35241643
  4. 4. Glockzin K et al.. 2022. Characterization of adenine phosphoribosyltransferase (APRT) activity in Trypanosoma brucei brucei: Only one of the two isoforms is kinetically active.. PLoS Negl Trop Dis 16(2):e0009926 PMID: 35104286
  5. 5. Woods RA et al.. 1984. Adenine phosphoribosyltransferase mutants in Saccharomyces cerevisiae.. J Gen Microbiol 130(10):2629-37 PMID: 6392474
  6. 6. Harambat J et al.. 2012. Adenine phosphoribosyltransferase deficiency in children.. Pediatr Nephrol 27(4):571-9 PMID: 22212387
  7. 7. Nicholls PB et al.. 1968. Adenine phosphoribosyltransferase in plant tissues: some effects of kinetin on enzymic activity.. Plant Physiol 43(4):645-8 PMID: 16656820
  8. 8. Itai R et al.. 2000. Induced activity of adenine phosphoribosyltransferase (APRT) in iron-deficiency barley roots: a possible role for phytosiderophore production.. J Exp Bot 51(348):1179-88 PMID: 10937693
Contact Us
*
*
*
*
How did you hear about us: